Showing results 7 to 12 of 12
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2021 | 10 | |||
2020 | 59 | |||
2021 | 44 | |||
Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B (CHB) shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International | 2022 | |||
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold Proceeding/Conference:Journal of Hepatology | 2019 | 73 | ||
2020 | 78 |